Executive impairment determines ADHD medication response: implications for academic achievement
James B Hale1, Linda A Reddy, Margaret Semrud-Clikeman
1Professor, Department of Psychology, University of Victoria, Victoria, British Columbia, Canada. jbhale@uvic.ca
Journal of Learning Disabilities
|March 9, 2011
Summary
Methylphenidate (MPH) effectively treats attention-deficit/hyperactivity disorder (ADHD) in children with significant executive-working memory (EWM) and self-regulation (SR) impairments. Optimal MPH dosing for cognitive function may differ from behavioral improvements.
Area of Science:
- Neuroscience
- Child Psychology
- Pharmacology
Background:
- Methylphenidate (MPH) is commonly prescribed for attention-deficit/hyperactivity disorder (ADHD), primarily based on behavioral assessments.
- Current treatment approaches often lack direct neuropsychological data to guide MPH efficacy.
- Identifying specific cognitive deficits, such as executive-working memory (EWM) and self-regulation (SR), may refine ADHD diagnosis and treatment.
Purpose of the Study:
- To investigate the impact of MPH on cognitive and behavioral outcomes in children with ADHD.
- To determine if baseline EWM and SR impairments predict MPH response.
- To explore dose-dependent effects of MPH on neuropsychological and behavioral measures.
Main Methods:
- A double-blind, placebo-controlled trial involving children aged 6-16 with ADHD (inattentive and combined types).
- Participants underwent MPH titration with placebo, low-dose, and high-dose conditions.
- EWM/SR measures, behavior ratings, and classroom observations were used to assess MPH response via nonparametric randomization tests.
Main Results:
- Children with significant baseline EWM/SR impairments showed robust cognitive and behavioral responses to MPH.
- Conversely, children with adequate baseline EWM/SR performed poorly with MPH treatment.
- The optimal MPH dose for improving neuropsychological functioning was often lower than that for behavioral improvement.
Conclusions:
- Baseline EWM and SR deficits are critical indicators for predicting MPH treatment success in ADHD.
- The discrepancy between optimal cognitive and behavioral MPH doses may explain limited long-term academic gains.
- This study suggests a need to incorporate neuropsychological assessments into ADHD medication titration for improved academic outcomes.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:30Information Processing Approach
The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is also...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...